Cryoablation Combined With Tislelizumab Plus Lenvatinib In Previously Treated Gastric Cancer Liver Metastasis (CASTLE-09)

Clinical trial NCT05893056 · UNKNOWN

Trial details

NCT number: NCT05893056
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Cancer Metastatic to Liver

Start date: 2023-06-16
Primary completion: 2025-12-30
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.